Pink SheetThe regenerative medicine sector continues to seek increased contact with the US Food and Drug Administration, even as the architects of the Center for Biologics Evaluation and Research review structu
Medtech InsightThe market for tissue-engineered skin replacements and wound modulators is expected to reach nearly $1.9bn in 2024, a faster rebound than certain other elective procedures that can be put on hold, acc
Pink SheetA provision in the US omnibus budget bill circumvents Medicare Part B reimbursement policy by reinstating "pass-through" payments in certain narrowly drawn circumstances. The bill is a disappointment
In VivoDevice Transactions Continuing the downward trend in financing over the past several quarters, the device industry collected $1.2 billion in Q2 funding, a 48% decrease from Q1's $2.3 billion total. It